Fifth Third Bancorp Common Stock vs Johnson & Johnson — how do they compare? Fifth Third Bancorp Common Stock trades at $50.36 (market cap $45.98B), while Johnson & Johnson trades at $260.64 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 13.4× Fifth Third Bancorp Common Stock's market cap, and Fifth Third Bancorp Common Stock pays the higher dividend (3.31%). Which is the better fit depends on your goals — on Pluang, investors hold Fifth Third Bancorp Common Stock for 1 Days and Johnson & Johnson for 129 Days on average.
| FITB | JNJ | |
|---|---|---|
Market Cap | $45.98B | $618.09B |
Volume | 10,522,320 | 6,050,983 |
Sector | Financials | Health |
52-Week High | $59.37 | $278.43 |
52-Week Low | $40.36 | $186.00 |
Typical Hold Time | 1 Days | 129 Days |
Enterprise Value | $63.85B | $646.37B |
Dividend Yield | 3.31% | 2.09% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Johnson & Johnson (JNJ) trades at $259.62, up 0.45% with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 21.48% net margin and 25.74% ROE, though valuation ratios appear elevated with P/E at 29.75. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with 52.5% buy ratings.
JNJ offers stable dividend income and pharmaceutical innovation upside, but faces patent cliff risks and increasing debt-to-asset ratio (24.06% in 2025). Analyst consensus target of $286.53 suggests 10% upside potential, though technical resistance at $260 may limit near-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Fifth Third Bancorp provides retail and commercial banking, lending, payments, and wealth management services in the United States.
Read more on FITB →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →